Liang, Qiansheng http://orcid.org/0009-0009-0856-1957
Chi, Gamma http://orcid.org/0000-0001-9910-0965
Cirqueira, Leonardo http://orcid.org/0000-0001-7335-174X
Zhi, Lianteng
Marasco, Agostino http://orcid.org/0009-0008-6875-653X
Pilati, Nadia
Gunthorpe, Martin J. http://orcid.org/0000-0002-0216-1735
Alvaro, Giuseppe
Large, Charles H. http://orcid.org/0000-0001-9814-7737
Sauer, David B. http://orcid.org/0000-0001-9291-4640
Treptow, Werner http://orcid.org/0000-0003-4564-3205
Covarrubias, Manuel http://orcid.org/0000-0002-0881-4143
Funding for this research was provided by:
Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (200114/2020-4)
Wellcome Trust (106169/Z/14/Z)
Innovative Medicines Initiative (875510)
Article History
Received: 10 April 2023
Accepted: 11 March 2024
First Online: 21 March 2024
Competing interests
: A.M., N.P., G.A., M.J.G. and C.H.L. are employees and shareholders of Autifony Therapeutics, Ltd. Q.L., L.Z. and M.C. received funding from Autifony Therapeutics, Ltd. to conduct this work. The remaining authors declare no competing interests.